No registrations found.
ID
Source
Brief title
Health condition
Decision aid for Localised Prostate cancer
Prostaatkanker keuzehulp
Sponsors and support
Nijmegen, the Netherlands
Intervention
Outcome measures
Primary outcome
Implementation rate of the decision aid in routine care
Barriers and facilitators for decision aid use
Secondary outcome
Effect of the Decision aid on:
Decisional conflict
Prostate cancer knowledge
Background summary
To address the limited use of decision support in oncology daily practice, the implementation of a decision aids (DA) is studied in patients with localized prostate cancer who had more than one treatment option (surgery, external radiotherapy, brachytherapy and/or active surveillance). This study focusses primarily on the barriers and facilitators for DA use.
Both care providers and patients fill out questionnaires on decision making and on the use of the DA. The implementation rate was calculated as the portion of eligible patients that received a DA, using national cancer registry data on the number of eligible patients per hospital.
In addition, the effect of the DA is studied by comparing the intervention group (receiving usual care plus DA) with a control group (receiving usual care without DA).
Study objective
The implementation rate of the decision aid in daily care is expected to depend on barriers perceived by care providers and/or patients.
Use of the decision aid is expecetd to decrease decisional conflict and increase knowledge in patients.
Study design
Patient questionnaires were filled out after the treatment choice was made but before the treatment was carried out.
Care provider questionnaires were filled out after about nine months of using the decision aid
Intervention
Care providers present a decision aid to their patients with prostate cancer to involve them in the choice of their treatment.
Care providers and patients fill out questionnaires.
A control group of patients receive usual care without decision aid. They also fill out questionnaires.
Julia van Tol-Geerdink
Nijmegen 6500 HB
The Netherlands
024-3614515
julia.vantol-geerdink@radboudumc.nl
Julia van Tol-Geerdink
Nijmegen 6500 HB
The Netherlands
024-3614515
julia.vantol-geerdink@radboudumc.nl
Inclusion criteria
Men with localized prostate cancer
Eligible for two or more treatment options
Exclusion criteria
Insufficient knowledge of the Dutch language
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6098 |
| NTR-old | NTR6245 |
| Other | Radboudumc : CZ-201300071 |
Summary results
* van Tol-Geerdink JJ, Cuypers M, Al-Itejawi HHM, van Uden-Kraan CF, de Vries M, Stalmeier PFM. Implementation and effect of three Dutch decision aids for prostate cancer; Results from the JIPPA study. Eur Urol S15 (13), E1580-1581, 2016
* Cuypers M, Lamers R, Kil P, van Tol-Geerdink J, van Uden-Kraan C, van de Poll-Franse L, de Vries M. Uptake and usage of an online prostate cancer treatment decision aid in Dutch clinical practice: A quantitative analysis from the PCPCC trial. Health Informatics Journal 25(4), 1498–1510, 2019
* van Tol-Geerdink JJ, Somford DM, van Oort IM, Wijburg CJ, Geboers AD, van Uden C, de Vries M, Stalmeier PFM. Implementation of a decision aid for localized prostate cancer in routine care; A successful implementation strategy. Health Informatics Journal doi: 10.1177/1460458219873528 (epub 2019)